Fulcrum Therapeutics, Inc.

NASDAQ:FULC

3.57 (USD) • At close April 28, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 008000.8710.7590.880.2950.6851.1831.8822.5925.0584.9354.3814.7894.2251.84820.7500000000
Kosten van de omzet 0017.2610.4790.5080.50.60.5660.5910.625.0190.5360.62117.07717.37816.33418.86814.86112.77514.4829.8413.49610.8634.6290000
Brutowinst 0062.739-0.4790.3630.2590.28-0.2710.0940.583-23.1372.0564.437-12.142-12.997-11.545-14.643-13.013-10.775-13.732-9.84-13.496-10.86-34.6290000
Brutowinstmarge 000.78400.4170.3410.318-0.9190.1370.493-12.2940.7930.877-2.46-2.967-2.411-3.466-7.042-5.388-18.30900000000
Onderzoek- en ontwikkelingskosten 11.71314.63917.26119.29418.99918.23817.84916.71518.56615.36625.01917.83118.91217.07717.37816.33416.14515.6412.77514.48212.08713.49610.8634.6296.866.9635.7885.573
Algemene en administratieve kosten 7.7168.42410.24710.0619.8649.96110.32311.5210.139.70711.09810.7599.7058.6286.6855.4985.8675.3125.1495.0644.4033.512.6342.5982.3912.1252.0611.737
Verkoop- en marketingkosten 0000-0.50800000000000000000000000
Verkoop-, algemene en administratieve kosten 7.7168.42410.24710.0619.3569.96110.32311.5210.139.70711.09810.7599.7058.6286.6855.4985.8675.3125.1495.0644.4033.512.6342.5982.3912.1252.0611.737
Overige kosten 02.06302.9643.2363.4233.5093.1611.8380.6170.1650.070.0750.0540.0340.0440.0670.1420.2390.3440.0070.0070.0080.0070.0070.0070.0080.37
Bedrijfskosten 19.42925.12627.50829.35528.35528.19928.17228.23528.69625.07336.11728.5928.61725.70524.06321.83222.01220.95217.92419.54616.4917.00613.49437.2279.2519.0887.8497.31
Bedrijfsresultaat -19.429-25.12652.492-29.834-27.992-27.44-27.292-27.94-27.973-24.355-34.235-25.998-23.559-20.77-19.682-17.043-17.787-19.104-15.924-18.796-16.49-17.006-13.494-37.227-9.251-9.088-7.849-7.31
Bedrijfsresultaat ratio 000.6560-32.138-36.153-31.014-94.712-40.836-20.587-18.191-10.03-4.658-4.209-4.493-3.559-4.21-10.338-7.962-25.06100000000
Totaal overige inkomsten en kosten netto 2.8613.432.9172.9643.2363.4233.5093.1611.8380.6170.1650.070.0750.0540.0340.0440.0670.1420.2390.3440.3670.4640.3250.3840.3920.1450.0030.37
Inkomen voor belasting -16.568-21.69655.409-26.87-24.756-24.017-23.783-24.779-26.135-23.738-34.07-25.928-23.484-20.716-19.648-16.999-17.72-18.962-15.685-18.452-16.123-16.542-13.169-36.843-8.859-8.943-7.846-6.94
Inkomen voor belasting ratio 000.6930-28.423-31.643-27.026-83.997-38.153-20.066-18.103-10.003-4.643-4.198-4.485-3.55-4.194-10.261-7.843-24.60300000000
Belastingkosten 0000.4353.1610.4090.525-3.161-2.5050.313-0.024-0.07-0.6210.019-0.0280-0.733000-0.879-0.457-0.317-0.377-0.385-0.1380.0050
Nettowinst -16.568-21.69655.409-26.87-24.756-24.017-23.783-21.618-23.63-24.051-34.07-25.858-23.484-20.716-19.648-16.999-17.72-18.962-15.685-18.452-16.123-16.542-13.169-36.843-8.859-8.943-7.846-6.94
Nettowinstmarge 000.6930-28.423-31.643-27.026-73.281-34.496-20.331-18.103-9.976-4.643-4.198-4.485-3.55-4.194-10.261-7.843-24.60300000000
WPA (Winst Per Aandeel) -0.31-0.350.89-0.43-0.4-0.39-0.38-0.36-0.45-0.52-0.83-0.64-0.58-0.57-0.6-0.54-0.64-0.7-0.66-0.81-0.71-0.93-0.56-1.58-0.52-0.53-0.46-0.41
Verwaterde WPA -0.31-0.350.87-0.43-0.4-0.39-0.38-0.36-0.45-0.52-0.83-0.64-0.58-0.57-0.6-0.54-0.64-0.7-0.66-0.81-0.71-0.93-0.56-1.58-0.52-0.53-0.46-0.41
EBITDA -19.06-22.69455.809-29.355-27.484-26.909-26.725-27.374-27.42-23.279-33.559-25.462-22.938-20.151-19.01-16.44-17.054-18.55-15.371-18.257-15.971-16.49-12.98-36.723-8.742-8.629-7.646-7.136
EBITDA ratio 000.6980-31.555-35.453-30.369-92.793-40.029-19.678-17.832-9.823-4.535-4.083-4.339-3.433-4.036-10.038-7.686-24.34300000000